irsogladine has been researched along with Glioma in 1 studies
irsogladine: RN given refers to parent cpd; MN 1695 refers to maleate salt
Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mori, T | 1 |
| Abe, T | 1 |
| Wakabayashi, Y | 1 |
| Hikawa, T | 1 |
| Matsuo, K | 1 |
| Yamada, Y | 1 |
| Kuwano, M | 1 |
| Hori, S | 1 |
1 other study available for irsogladine and Glioma
| Article | Year |
|---|---|
Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-alpha or basic fibroblast growth factor.
Topics: Fibroblast Growth Factor 2; Glioma; Humans; Neoplasm Invasiveness; Receptors, Cell Surface; Receptor | 2000 |